Patents by Inventor Mark E. Goldman

Mark E. Goldman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7155749
    Abstract: A cartridge has lower and upper plates, vertically oriented front, rear and side plates and a rotatable cylindrical core supported adjacent to its ends between the side plates. A roll of paper constitutes covers attached to the core. A free end extends through the opening and terminates at a forward end of a seat. The paper is comprised of consecutive lengths separated by transverse perforations with a tab centrally located and forwardly extending. Each length has a lower surface with an adhesive.
    Type: Grant
    Filed: April 5, 2004
    Date of Patent: January 2, 2007
    Inventors: Ida Gelbart, Mark E. Goldman
  • Publication number: 20040186132
    Abstract: Non-steroidal compounds which are high affinity, high selectivity modulators for steroid receptors are disclosed. Also disclosed are pharmaceutical compositions incorporating such compounds, methods for employing the disclosed compounds and compositions for treating patients requiring steroid receptor agonist or antagonist therapy, intermediates useful in the preparation of the compounds and processes for the preparation of the steroid receptor modulator compounds.
    Type: Application
    Filed: December 17, 2003
    Publication date: September 23, 2004
    Inventors: Todd K. Jones, Mark E. Goldman, Charlotte L. F. Pooley, David T. Winn, James P. Edwards, Sarah J. West, Christopher M. Tegley, Lin Zhi, Lawrence G. Hamann, Luc J. Farmer, Robert L. Davis
  • Patent number: 6696459
    Abstract: Non-steroidal compounds which are high affinity, high selectivity modulators for steroid receptors are disclosed. Also disclosed are pharmaceutical compositions incorporating such compounds, methods for employing the disclosed compounds and compositions for treating patients requiring steroid receptor agonist or antagonist therapy, intermediates useful in the preparation of the compounds and processes for the preparation of the steroid receptor modulator compounds.
    Type: Grant
    Filed: October 14, 1997
    Date of Patent: February 24, 2004
    Assignee: Ligand Pharmaceuticals Inc.
    Inventors: Todd K. Jones, Mark E. Goldman, Charlotte L. F. Pooley, David T. Winn, James P. Edwards, Sarah J. West, Christopher M. Tegley, Lin Zhi, Lawrence G. Hamann, Luc J. Farmer, Robert L. Davis
  • Patent number: 6692414
    Abstract: A seat bound exercise system provides resistive rotational motion of the ankle to combat potentially fatal problems such as lower leg thrombosis. The system comprises an attachment member with upper and lower ends. The lower end is provided with a bore and extends to a ground surface. A support cylinder with a top end, a bottom end, an inner edge and an outer edge is provided. The bottom end has a coaxial bore allowing rotatable coupling with a bore of the attachment members with a pin. A handle bar, including a cylindrical receiving bar and a cylindrical intermediate portion, is provided next. The receiving bar has a lower portion telescoping over and coupled to the top ends of the support cylinders and upper portion. The intermediate bar telescopes over and is coupled to the receiving bar. Also included is a source of resistance force with piston rods. A foot pedal with a foot receiving portion is provided.
    Type: Grant
    Filed: June 6, 2001
    Date of Patent: February 17, 2004
    Inventors: Ida Gelbart, S. Samuel Gelbart, Mark E. Goldman
  • Patent number: 6321430
    Abstract: A system for holding or transporting engraveable workpieces of different configurations is provided. The system includes a first workpiece carrier that has an internal relief configured to receive a first workpiece having a first configuration. The system also includes a second workpiece carrier that has an internal relief configured to receive a second workpiece having a second configuration. The outer surface of the second workpiece carrier is substantially the same as the outer shape of the first workpiece carrier, to thereby provide a carrier of uniform outer dimensions regardless of the workpiece configuration. The carrier may hold the workpiece within the internal relief through a snap lock and in such a manner as to avoid contact with and possible damage from an adjacently stored workpiece.
    Type: Grant
    Filed: December 4, 1998
    Date of Patent: November 27, 2001
    Assignee: Axxess Technologies, Inc.
    Inventors: Mark E. Goldman, Michael A. Mueller
  • Patent number: 6093821
    Abstract: Non-steroidal compounds which are high affinity, high selectivity modulators for steroid receptors are disclosed. Also disclosed are pharmaceutical compositions incorporating such compounds, methods for employing the disclosed compounds and compositions for treating patients requiring steroid receptor agonist or antagonist therapy, intermediates useful in the preparation of the compounds and processes for the preparation of the steroid receptor modulator compounds.
    Type: Grant
    Filed: October 8, 1997
    Date of Patent: July 25, 2000
    Assignee: Ligand Pharmaceuticals Incorporated
    Inventors: Todd K. Jones, Mark E. Goldman, Charlotte L. F. Pooley, David T. Winn, James P. Edwards, Sarah J. West, Christopher M. Tegley, Lin Zhi
  • Patent number: 5811428
    Abstract: Compounds having utility as antinflammatory agents in general and, more specifically, for the prevention and/or treatment of immunoinflammatory and autoimmune diseases are disclosed. The compounds are pyrimidine- or pyrazine-containing compounds and, in one embodiment, are carboxyamides of the same. Methods are also disclosed for preventing and/or treating inflammatory conditions by administering to an animal in need thereof an effective amount of a compound of this invention, preferably in the form of a pharmaceutical composition.
    Type: Grant
    Filed: December 18, 1995
    Date of Patent: September 22, 1998
    Assignee: Signal Pharmaceuticals, Inc.
    Inventors: Mark J. Suto, Mark E. Goldman, Leah M. Gayo, Lynn J. Ransone-Fong, Moorthy S. S. Palanki, Robert W. Sullivan
  • Patent number: 5696130
    Abstract: Non-steroidal compounds which are high affinity, high selectivity modulators for steroid receptors are disclosed. Also disclosed are pharmaceutical compositions incorporating such compounds, methods for employing the disclosed compounds and compositions for treating patients requiring steroid receptor agonist or antagonist therapy, intermediates useful in the preparation of the compounds and processes for the preparation of the steroid receptor modulator compounds.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: December 9, 1997
    Assignee: Ligand Pharmaceuticals Incorporated
    Inventors: Todd K. Jones, David T. Winn, Mark E. Goldman, Lawrence G. Hamann, Lin Zhi, Luc J. Farmer, Robert L. Davis
  • Patent number: 5696133
    Abstract: Non-steroidal compounds which are high affinity, high selectivity modulators for steroid receptors are disclosed. Also disclosed are pharmaceutical compositions incorporating such compounds, methods for employing the disclosed compounds and compositions for treating patients requiting steroid receptor agonist or antagonist therapy, intermediates useful in the preparation of the compounds and processes for the preparation of the steroid receptor modulator compounds.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: December 9, 1997
    Assignee: Ligand Pharmaceuticals Incorporated
    Inventors: Todd K. Jones, Mark E. Goldman, Charlotte L.F. Pooley, David T. Winn, James P. Edwards, Sarah J. West, Christopher M. Tegley, Lin Zhi, Lawrence G. Hamann, Luc J. Farmer, Robert L. Davis
  • Patent number: 5688810
    Abstract: Non-steroidal compounds which are high affinity, high selectivity modulators for steroid receptors are disclosed. Also disclosed are pharmaceutical compositions incorporating such compounds, methods for employing the disclosed compounds and compositions for treating patients requiring steroid receptor agonist or antagonist therapy, intermediates useful in the preparation of the compounds and processes for the preparation of the steroid receptor modulator compounds.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: November 18, 1997
    Assignee: Ligand Pharmaceuticals Incorporated
    Inventors: Todd K. Jones, Mark E. Goldman, Charlotte L.F. Pooley, David T. Winn, James P. Edwards, Sarah J. West, Christopher M. Tegley, Lin Zhi
  • Patent number: 5677336
    Abstract: Non-steroidal compounds which are high affinity, high specificity ligand antagonists for the androgen receptor are disclosed. Also disclosed are methods for employing the disclosed compounds for modulating processes mediated by the androgen receptor and for treating patients requiring androgen receptor antagonist therapy.
    Type: Grant
    Filed: October 21, 1993
    Date of Patent: October 14, 1997
    Assignee: Ligand Pharmaceuticals Incorporated
    Inventors: Todd K. Jones, Lawrence G. Hamann, Luc Farmer, Michael G. Johnson, Mark E. Goldman
  • Patent number: 5569003
    Abstract: An automated apparatus and method for engraving a workpiece selected from a plurality of workpiece styles, and dispensing the engraved workpiece along with a related accessory. Upon receipt of workpiece selection and text information supplied by a user, the controller generates drive signal which cause the apparatus to: retrieve the selected workpiece from one of a plurality of workpiece storage columns, move the workpiece to an engraving location, engrave the workpiece using a workpiece-specific engraving tool pressure, and dispense of the accessory from one of a plurality of accessory storage columns.
    Type: Grant
    Filed: May 13, 1994
    Date of Patent: October 29, 1996
    Assignee: Quick-Tag, Inc.
    Inventors: Mark E. Goldman, Michel A. Aubert, Alexander M. Shenderovich, Jagat R. Acharya
  • Patent number: 5527819
    Abstract: Novel indole compounds inhibit HIV reverse transcriptase, and are useful in the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, anti-infectives, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: June 18, 1996
    Assignee: Merck & Co., Inc.
    Inventors: Theresa M. Williams, Terrence M. Ciccarone, Walfred S. Saari, John S. Wai, William J. Greenlee, Suresh K. Balani, Mark E. Goldman, Anthony D. Theoharides, deceased, Jacob M. Hoffman, Jr., William C. Lumma, Jr., Joel R. Huff, Clarence S. Rooney, Philip E. Sanderson
  • Patent number: D362689
    Type: Grant
    Filed: May 13, 1994
    Date of Patent: September 26, 1995
    Assignee: Quick-Tag, Inc.
    Inventors: Mark E. Goldman, William J. Stone, III, Alexander M. Shenderovich